慢性HBV感染孕妇妊娠期及分娩后病毒学和肝功能变化的特点及机制

赵梦鱼; 邹怀宾; 陈煜; 郑素军; 段钟平

doi:10.3969/j.issn.1001-5256.2019.06.038

慢性HBV感染孕妇妊娠期及分娩后病毒学和肝功能变化的特点及机制

DOI: 10.3969/j.issn.1001-5256.2019.06.038

基金项目:

国家科技重大专项“艾滋病和病毒性肝炎等重大传染病防治”(2017ZX10201201-001-001,2017ZX10201201-002-002)；北京市科学技术委员会资助(Z151100003915096,Z161100000516084)；

详细信息

中图分类号: R714.251
计量
- 文章访问数: 1048
- HTML全文浏览量: 26
- PDF下载量: 323
- 被引次数: 0
出版历程
- 收稿日期: 2018-12-11
- 出版日期: 2019-06-20

Characteristics and mechanism of virological and liver function changes in pregnant women with chronic hepatitis B virus infection during pregnancy and after delivery

Research funding:

摘要

摘要: HBV感染的孕妇妊娠期间自身机体的变化(体内激素水平及免疫状态)或抗病毒治疗后停药等均可能会导致病毒学改变及肝功能异常,严重者可导致不良结局。因此,加强对慢性HBV感染孕妇妊娠期及分娩后的病毒学指标及肝功能的监测有助于及时发现孕妇机体变化情况,从而避免肝炎发作甚至重型肝炎等不良后果的发生。现就慢性HBV感染孕妇妊娠期及分娩后病毒学及肝功能变化的特点及机制的文献作一综述,为提高临床医生对慢性HBV感染的孕妇妊娠期及分娩后管理水平提供理论支持。
- 乙型肝炎病毒 /
- 孕妇 /
- 病毒学 /
- 肝功能 /
- 综述
Abstract: In pregnant women with hepatitis B virus (HBV) infection, body changes (hormone levels and immune status) during pregnancy or drug withdrawal after antiviral therapy may lead to virological changes, abnormal liver function, and even adverse outcomes in severe cases. Therefore, strengthening the monitoring of virological indicators and liver function in pregnant women with chronic HBV infection during pregnancy and after delivery can help to find body changes in time and thus prevent the adverse outcomes such as hepatitis and liver failure.This article reviews the articles on the characteristics and mechanisms of virological and liver function changes in pregnant women with chronic HBV infection during pregnancy and after delivery, in order to provide theoretical support for clinicians on the management of pregnant women with chronic HBV infection during pregnancy and after delivery.
- hepatitis B virus /
- pregnant woman /
- virology /
- liver function /
- review

HTML全文

参考文献(43)

[1]European Association for the Study of the Liver.EASL clinical practice guidelines:Management of chronic hepatitis B virus infection[J].J Hepatol, 2012, 57 (1) :167-185.

[2]PAN CQ, DUAN Z, DAI E, et al.Tenofovir to prevent hepatitis B transmission in mothers with high viral load[J].N Engl JMed, 2016, 374 (24) :2324-2334.

[3]VODKIN I, PATTON H.Management of hepatitis B virus infection during pregnancy[J].Minerva Gastroenterol Dietol, 2014, 60 (4) :205-214.

[4]LEUNG N.Chronic hepatitis B in Asian women of childbearing age[J].Hepatol Int, 2009, 3 (Suppl 1) :24-31.

[5]PETROVA M, KAMBUROV V.Breastfeeding and chronic HBVinfection:Clinical and social implications[J].World J Gastroenterol, 2010, 16 (40) :5042-5046.

[6]XIN X, WANG Y, CHENG J, et al.Seroepidemiological survey of hepatitis B virus infection among 764, 460 women of childbearing age in rural China:A cross-sectional study[J].JClin Virol, 2016, 81:47-52.

[7]ZHAO SH, HAN LY, ZHANG LH, et al.Study of the harm of HBV infection on mother and fetus and the preventive[J].JNorman Bethune Univ (Med Sci) , 2000, 26 (1) :75. (in Chinese) 赵淑华, 韩丽英, 张立会, 等.乙型肝炎病毒携带者妊娠对母婴的危害及预防措施的研究[J].白求恩医科大学学报, 2000, 26 (1) :75.

[8]YANG YB, LI XM, ZHOU YS, et al.Association of hepatitis Bvirus infection during pregnancy with mother-child prognosis[J].Chin J Pract Gynecol Obstetr, 2004, 20 (6) :371-372. (in Chinese) 杨越波, 李小毛, 周永生, 等.妊娠合并乙型肝炎病毒感染与母儿预后的关系[J].中国实用妇科与产科杂志, 2004, 20 (6) :371-372.

[9]TAN HH, LUI HF, CHOW WC.Chronic hepatitis B virus (HBV) infection in pregnancy[J].Hepatol Int, 2008, 2 (3) :370-375.

[10]SAFIR A, LEVY A, SIKULER E, et al.Maternal hepatitis B virus or hepatitis C virus carrier status as an independent risk factor for adverse perinatal outcome[J].Liver Int, 2010, 30 (5) :765-770.

[11]SODERSTROM A, NORKRANS G, LINDH M.Hepatitis B virus DNA during pregnancy and post partum:Aspects on vertical transmission[J].Scand J Infect Dis, 2003, 35 (11-12) :814-819.

[12]LIN HH, CHEN PJ, CHEN DS, et al.Postpartum subsidence of hepatitis B viral replication in HBe Ag-positive carrier mothers[J].J Med Virol, 1989, 29 (1) :1-6.

[13]JONAS MM.Hepatitis B and pregnancy:An underestimated issue[J].Liver Int, 2009, 29 (Suppl 1) :133-139.

[14]RUAN SM, ZHOU J, SHAN ZL, et al.Pregnancy and postpartum hepatitis activity in pregnant women with high viral load of HBV infection[J].Prog Obstet Gynecol, 2018, 27 (6) :458-461. (in Chinese) 阮晟鸣, 周健, 单震丽, 等.HBV感染高病毒载量孕妇孕期及产后肝炎活动情况[J].现代妇产科进展, 2018, 27 (6) :458-461.

[15]ter BORG MJ, LEEMANS WF, DE MAN RA, et al.Exacerbation of chronic hepatitis B infection after delivery[J].J Viral Hepat, 2008, 15 (1) :37-41.

[16]CAO YJ, YI W, LIU M, et al.Postpartum observation of changes in liver function of pregnant women with hepatitis B virus infection in immune tolerant phase[J/CD].Chin J Exp Clin Infect Dis:Electronic Edition, 2013, 7 (3) :111-114. (in Chinese) 曹彦君, 易为, 刘敏, 等.免疫耐受期HBV感染的孕妇产后肝功能变化[J/CD].中华实验和临床感染病杂志:电子版, 2013, 7 (3) :111-114.

[17]WANG XX, HAN GR, JIANG HX, et al.Observation on postpartum changes in liver function of pregnant women with chronic HBV infection[J].Occup Health, 2016, 32 (4) :498-501. (in Chinese) 王习习, 韩国荣, 江红秀, 等.慢性乙型肝炎病毒感染孕妇产后肝功能的变化[J].职业与健康, 2016, 32 (4) :498-501.

[18]YI W, PAN CQ, LI MH, et al.The characteristics and predictors of postpartum hepatitis flares in women with chronic hepatitis B[J].Am J Gastroenterol, 2018, 113 (5) :686-693.

[19]LIU J, LEE MH, BATRLA-UTERMANN R, et al.A predictive scoring system for the seroclearance of HBsAg in HBe Ag-seronegative chronic hepatitis B patients with genotype B or C infection[J].J Hepatol, 2013, 58 (5) :853-860.

[20]ZHOU P.Clinical follow-up analysis of mother to child transmission of hepatitis B[D].Guangzhou:Southern Medical University, 2017:34-35. (in Chinese) 周佩.乙型肝炎母婴传播阻断的临床随访分析[D].广州:南方医科大学, 2017:34-35.

[21]YUE L, TAN JY, LI SH, et al.Research advances in the mechanism of immune tolerance during pregnancy[J].Matern Child Health Care China, 2012, 27 (5) :784-786. (in Chinese) 岳兰, 谭继英, 李少红, 等.妊娠免疫耐受机制的研究进展[J].中国妇幼保健, 2012, 27 (5) :784-786.

[22]DING Y, SHENG QJ, MA L, et al.Chronic HBV infection among pregnant women and their infants in Shengyang, China[J].Virol J, 2013, 10 (1) :17.

[23]WANG SJ, SHENG QJ, WU YY, et al.Comparative study of the serological and virological characteristics in pregnant women with chronic HBV infection between 2016 and 2010[J].Chin J Pract Intern Med, 2017, 37 (12) :1079-1081. (in Chinese) 王岁晶, 盛秋菊, 吴宇宇, 等.慢性乙型肝炎病毒感染孕妇血清学及病毒学特征---沈阳部分地区2016年与2010年对比研究[J].中国实用内科杂志, 2017, 37 (12) :1079-1081.

[24]GILES ML, VISVANATHAN K, LEWIN SR, et al.Chronic hepatitis B infection and pregnancy[J].Obstet Gynecol Surv, 2012, 67 (1) :37-44.

[25]AAGAARD-TILLERY KM, SILVER R, DALTON J.Immunology of normal pregnancy[J].Semin Fetal Neonatal Med, 2006, 11 (5) :279-295.

[26]BETZ AG.Immunology:Tolerating pregnancy[J].Nature, 2012, 490 (7418) :47-48.

[27]Chinese Society of Hepatology and Chinese Society of Infectious Diseases Chinese, Medical Association.The guideline of prevention and treatment for chronic hepatitis B:A 2015 update[J].J Clin Hepatol, 2015, 31 (12) :1941-1960. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2015年更新版) [J].临床肝胆病杂志, 2015, 31 (12) :1941-1960.

[28]TERRAULT NA, LOK ASF, MCMAHON BJ, et al.Update on prevention, diagnosis, and treatment of chronic hepatitis B:AASLD 2018 hepatitis B guidance[J].Hepatology, 2018, 67 (4) :1560-1599.

[29]European Association for the Study of the Liver.EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure[J].J Hepatol, 2017, 66 (5) :1047-1081.

[30]SARIN SK, KUMAR M, LAU GK, et al.Asian-Pacific clinical practice guidelines on the management of hepatitis B:A 2015update[J].Hepatol Int, 2016, 10 (1) :1-98.

[31]DING Y, YOU H, REN H, et al.Consensus on the management of hepatitis B virus infection in women of childbearing age[J].J Clin Hepatol, 2018, 34 (6) :1176-1180. (in Chinese) 丁洋, 尤红, 任红, 等.感染乙型肝炎病毒的育龄女性临床管理共识[J].临床肝胆病杂志, 2018, 34 (6) :1176-1180.

[32]CHEN HL, LEE CN, CHANG CH, et al.Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus[J].Hepatology, 2015, 62 (2) :375-386.

[33]CELEN MK, MERT D, AY M, et al.Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection[J].World J Gastroenterol, 2013, 19 (48) :9377-9382.

[34]JOURDAIN G, NGO-GIANG-HUONG N, HARRISON L, et al.Tenofovir versus placebo to prevent perinatal transmission of hepatitis B[J].N Engl J Med, 2018, 378 (10) :911-923.

[35]NGUYEN V, TAN PK, GREENUP AJ, et al.Anti-viral therapy for prevention of perinatal HBV transmission:Extending therapy beyond birth does not protect against post-partum flare[J].Aliment Pharmacol Ther, 2014, 39 (10) :1225-1234.

[36]ZHANG H, PAN CQ, PANG Q, et al.Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice[J].Hepatology, 2014, 60 (2) :468-476.

[37]FU D, LIU M, YI W, et al.Analysis on 23 cases of liver disease flare of pregnant women with inactive HBV infection[J/CD].Chin J Liver Dis:Electronic Edition, 2015, 7 (2) :49-52. (in Chinese) 付冬, 刘敏, 易为, 等.非活动期HBV感染妇女孕期肝病再活动23例分析[J/CD].中国肝脏病杂志:电子版, 2015, 7 (2) :49-52.

[38]CHIEN TL, WANG JH, KEE KM, et al.Factors predicting HB-sAg seroclearance and alanine transaminase elevation in HBe Ag-negative hepatitis B virus-infected patients with persistently normal liver function?[J].PLo S One, 2016, 11 (12) :e0166543.

[39]XU CY, LIU JL, LIU LH, et al.Levels of hepatitis B virus and its antigen in pregnant and non-pregnant women of childbearing age:A comparative analysis[J].Chin J Perinat Med, 2015, 18 (11) :828-831. (in Chinese) 徐陈瑜, 刘景丽, 刘兰华, 等.妊娠和非妊娠育龄妇女体内乙型肝炎病毒及其抗原水平比较[J].中华围产医学杂志, 2015, 18 (11) :828-831.

[40]MI L, KARSDON J, HUANG WM.Outcomes of eight Chinese-Americans pregnant patients with chronic hepatitis B (CHB) treated with tenofovir DF (TDF) during pregnancy[C].USA, The 61st Annual Meeting of AASLD, Boston, 2010.

[41]JIANG XN, FAN LY, LI DZ, et al.Clinical trial of telbivudine in the treatment of chronic hepatitis B in patients during the third trimester of pregnancy[J].J Clin Hepatol, 2013, 29 (2) :101-103. (in Chinese) 姜秀浓, 范玲燕, 李德周, 等.替比夫定治疗妊娠晚期慢性乙型肝炎孕妇的临床观察[J].临床肝胆病杂志, 2013, 29 (2) :101-103.

[42]BIAN Q, WANG M, ZHU YX, et al.Clinical study of nucleoside analogue therapy in pregnant women with chronic hepatitis B with abnormal liver function[J].Beijing Med J, 2016, 38 (12) :1330-1332. (in Chinese) 边茜, 王明, 朱云霞, 等.肝功能异常的慢性乙型肝炎孕妇应用核苷类似物治疗的临床研究[J].北京医学, 2016, 38 (12) :1330-1332.

[43]HAN GR, CAO MK, ZHAO W, et al.Aprospective andopentable study for the efficacy and safty of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitise B virus infection[J].Hepatology, 2011, 55 (6) :1215-1221.

施引文献

资源附件(0)

访问统计